[ad_1]
Federal regulators are likely to approve a third shot of Covid-19 for vaccinated adults starting at least six months after the second dose rather than the eight-month interval they previously announced, said a person familiar with them. plans, as the Biden administration steps up preparations for the delivery of boosters to the public.
Data from vaccine manufacturers and other countries reviewed by the Food and Drug Administration is based on boosters given at six months, the person said. The person said the approval of boosters for the three injections of Covid-19 administered in the United States – those manufactured by Pfizer Inc. and its partner BioNTech SE, Moderna Inc. and Johnson & Johnson – is expected in mid- September.
The Biden administration and the companies have said there should be enough supply for the boosters. The United States bought a billion combined doses of Pfizer and Moderna.
A White House spokesperson declined to comment. An FDA spokeswoman declined to comment on interactions with vaccine makers.
Pfizer and BioNTech said on Wednesday they had asked U.S. health officials to allow recalls of their Covid-19 vaccine and submitted additional data showing that a third dose improves protection against the virus. The FDA granted full approval for the vaccine on Monday. Officials in the Biden administration have said they hope full approval will encourage more people to get vaccinated, thereby increasing vaccination rates which recently passed 60% of the eligible U.S. population.
[ad_2]
Source link